Vivjoa Capsule
Product Images NDC 74695-823

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vivjoa (NDC 74695-823). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mycovia Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vivjoa 01)

Chemical structure diagram of oteseconazole, the active ingredient in VIVJOA 150 mg capsules. The molecular structure shows multiple ring systems, fluorine atoms, and other typical chemical bonds and groups as part of the compound's composition.*

FDA Label Image

Principal Display Panel (150 mg Blister Pack Label)

A dosing directions label for VIVJOA (oteseconazole) 150 mg capsules, indicating oral use. It provides instructions for Day 1 to take four capsules together and Day 2 to take three capsules together. From Week 2 to Week 12, it advises taking one capsule weekly starting Day 14. The label states the product is manufactured and distributed by Mycovia Pharmaceuticals, Inc., and is Rx only.*

FDA Label Image

Principal Display Panel (150 mg Capsule Blister Pack Container)

Packaging label for VIVJOA capsules containing oteseconazole 150 mg per capsule for oral use. The label shows a box designed to hold 18 capsules and includes the NDC 74695-823-18. The labeler is Mycovia Pharmaceuticals, Inc., and instructions are provided for dispensing. The label also advises users to press and hold a button to pull out the medication card and references the package insert for prescribing information.*

FDA Label Image

Principal Display Panel (150 mg Capsule Blister Pack Container Carton)

VIVJOA capsules packaging label displaying the brand name VIVJOA with the generic name oteseconazole. Each capsule contains 150 mg of oteseconazole for oral use. The label indicates the package contains 18 capsules, labeled for prescription use only, and manufactured by Mycovia Pharmaceuticals, Inc. The label also includes dosage directions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.